Literature DB >> 28742219

Model-free scoring system for risk prediction with application to hepatocellular carcinoma study.

Weining Shen1, Jing Ning2, Ying Yuan2, Anna S Lok3, Ziding Feng2.   

Abstract

There is an increasing need to construct a risk-prediction scoring system for survival data and identify important risk factors (e.g., biomarkers) for patient screening and treatment recommendation. However, most existing methodologies either rely on strong model assumptions (e.g., proportional hazards) or only handle binary outcomes. In this article, we propose a flexible method that simultaneously selects important risk factors and identifies the optimal linear combination of risk factors by maximizing a pseudo-likelihood function based on the time-dependent area under the receiver operating characteristic curve. Our method is particularly useful for risk evaluation and recommendation of optimal subsequent treatments. We show that the proposed method has desirable theoretical properties, including asymptotic normality and the oracle property after variable selection. Numerical performance is evaluated on several simulation data sets and an application to hepatocellular carcinoma data.
© 2017, The International Biometric Society.

Entities:  

Keywords:  Biomarker; Liver cancer; Risk prediction; Scoring system; Time-dependent AUC; Variable selection

Mesh:

Year:  2017        PMID: 28742219      PMCID: PMC5785588          DOI: 10.1111/biom.12750

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  27 in total

Review 1.  Emerging molecular markers of cancer.

Authors:  David Sidransky
Journal:  Nat Rev Cancer       Date:  2002-03       Impact factor: 60.716

2.  Combining several screening tests: optimality of the risk score.

Authors:  Martin W McIntosh; Margaret Sullivan Pepe
Journal:  Biometrics       Date:  2002-09       Impact factor: 2.571

3.  On linear combinations of biomarkers to improve diagnostic accuracy.

Authors:  Aiyi Liu; Enrique F Schisterman; Yan Zhu
Journal:  Stat Med       Date:  2005-01-15       Impact factor: 2.373

4.  Regularized ROC method for disease classification and biomarker selection with microarray data.

Authors:  Shuangge Ma; Jian Huang
Journal:  Bioinformatics       Date:  2005-10-18       Impact factor: 6.937

5.  Combining multiple biomarker models in logistic regression.

Authors:  Zheng Yuan; Debashis Ghosh
Journal:  Biometrics       Date:  2008-03-05       Impact factor: 2.571

6.  Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival.

Authors:  Valentina Santi; Franco Trevisani; Annagiulia Gramenzi; Alice Grignaschi; Federica Mirici-Cappa; Paolo Del Poggio; Maria Anna Di Nolfo; Luisa Benvegnù; Fabio Farinati; Marco Zoli; Edoardo Giovanni Giannini; Franco Borzio; Eugenio Caturelli; Maria Chiaramonte; Mauro Bernardi
Journal:  J Hepatol       Date:  2010-04-27       Impact factor: 25.083

7.  A direct method to evaluate the time-dependent predictive accuracy for biomarkers.

Authors:  Weining Shen; Jing Ning; Ying Yuan
Journal:  Biometrics       Date:  2015-03-10       Impact factor: 2.571

8.  Prognostic scoring systems in patients with follicular thyroid cancer: a comparison of different staging systems in predicting the patient outcome.

Authors:  A D'Avanzo; P Ituarte; P Treseler; E Kebebew; J Wu; M Wong; Q Y Duh; A E Siperstein; O H Clark
Journal:  Thyroid       Date:  2004-06       Impact factor: 6.568

9.  Diagnostic value of protein induced by vitamin K absence (PIVKAII) and hepatoma-specific band of serum gamma-glutamyl transferase (GGTII) as hepatocellular carcinoma markers complementary to alpha-fetoprotein.

Authors:  R Cui; J He; F Zhang; B Wang; H Ding; H Shen; Y Li; X Chen
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

10.  Application of the time-dependent ROC curves for prognostic accuracy with multiple biomarkers.

Authors:  Yingye Zheng; Tianxi Cai; Ziding Feng
Journal:  Biometrics       Date:  2006-03       Impact factor: 2.571

View more
  2 in total

1.  Breast cancer stage prediction: a computational approach guided by transcriptome analysis.

Authors:  K Athira; G Gopakumar
Journal:  Mol Genet Genomics       Date:  2022-08-03       Impact factor: 2.980

2.  Semiparametric isotonic regression analysis for risk assessment under nested case-control and case-cohort designs.

Authors:  Wen Li; Ruosha Li; Ziding Feng; Jing Ning
Journal:  Stat Methods Med Res       Date:  2019-12-22       Impact factor: 3.021

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.